BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18830959)

  • 1. Removal of envelope protein-free retroviral vectors by anion-exchange chromatography to improve product quality.
    Rodrigues T; Alves A; Lopes A; Carrondo MJ; Alves PM; Cruz PE
    J Sep Sci; 2008 Oct; 31(20):3509-18. PubMed ID: 18830959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaleable purification process for gene therapy retroviral vectors.
    Rodrigues T; Carvalho A; Carmo M; Carrondo MJ; Alves PM; Cruz PE
    J Gene Med; 2007 Apr; 9(4):233-43. PubMed ID: 17428003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors.
    Rodrigues T; Carvalho A; Roldão A; Carrondo MJ; Alves PM; Cruz PE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):59-68. PubMed ID: 16697280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
    Segura MM; Kamen A; Trudel P; Garnier A
    Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of retrovirus particles using heparin affinity chromatography.
    Segura MM; Kamen A; Garnier A
    Methods Mol Biol; 2008; 434():1-11. PubMed ID: 18470635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography.
    Qu G; Bahr-Davidson J; Prado J; Tai A; Cataniag F; McDonnell J; Zhou J; Hauck B; Luna J; Sommer JM; Smith P; Zhou S; Colosi P; High KA; Pierce GF; Wright JF
    J Virol Methods; 2007 Mar; 140(1-2):183-92. PubMed ID: 17196264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
    Tolmachov O
    Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications.
    Transfiguracion J; Jaalouk DE; Ghani K; Galipeau J; Kamen A
    Hum Gene Ther; 2003 Aug; 14(12):1139-53. PubMed ID: 12908966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifying the host range properties of retroviral vectors.
    Russell SJ; Cosset FL
    J Gene Med; 1999; 1(5):300-11. PubMed ID: 10738547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral cell targeting vectors.
    Buchholz CJ; Stitz J; Cichutek K
    Curr Opin Mol Ther; 1999 Oct; 1(5):613-21. PubMed ID: 11249668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein.
    Transfiguracion J; Coelho H; Kamen A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):167-73. PubMed ID: 15556530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of CD81 tetraspanin in human cells producing retroviral-based particles: tailoring vector composition.
    Rodrigues AF; Guerreiro MR; Santiago VM; Dalba C; Klatzmann D; Alves PM; Carrondo MJ; Coroadinha AS
    Biotechnol Bioeng; 2011 Nov; 108(11):2623-33. PubMed ID: 21656710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the isolation and purification of retroviral vectors for gene therapy.
    Braas G; Searle PF; Slater NK; Lyddiatt A
    Bioseparation; 1996; 6(4):211-28. PubMed ID: 9032984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of PERV-C env from domestic pig in Korea.
    Park SH; Bae EH; Park SM; Park JW; Lim MS; Jung YT
    J Microbiol Biotechnol; 2008 Oct; 18(10):1735-40. PubMed ID: 18955828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of chromatographic ion-exchange resins VI. Weak anion-exchange resins.
    Staby A; Jensen RH; Bensch M; Hubbuch J; Dünweber DL; Krarup J; Nielsen J; Lund M; Kidal S; Hansen TB; Jensen IH
    J Chromatogr A; 2007 Sep; 1164(1-2):82-94. PubMed ID: 17658538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An acidic cluster of the cytoplasmic tail of the RD114 virus glycoprotein controls assembly of retroviral envelopes.
    Bouard D; Sandrin V; Boson B; Nègre D; Thomas G; Granier C; Cosset FL
    Traffic; 2007 Jul; 8(7):835-47. PubMed ID: 17547695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the natural evolution to the genetic manipulation of the host-range of retroviruses.
    Dornburg R
    Biol Chem; 1997 Jun; 378(6):457-68. PubMed ID: 9224924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of osmotic pressure on the production of retroviral vectors: Enhancement in vector stability.
    Coroadinha AS; Silva AC; Pires E; Coelho A; Alves PM; Carrondo MJ
    Biotechnol Bioeng; 2006 Jun; 94(2):322-9. PubMed ID: 16528756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
    Segura MM; Kamen A; Garnier A
    Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.